Operative Standards for Cancer Surgery: Standards 5.3 - 5.8
In 2020, the Commission on Cancer (CoC) introduced new accreditation standards, Optimal Resources for Cancer Care (2020 Standards), that have undergone a significant change to focus on the provision of high-quality and measurable care. The American College of Surgeons (ACS) Quality Programs focus on the four principles of quality care: set the standards, build the right infrastructure, collect robust data, and verify through a third party. The CoC 2020 Standards take the next step in focusing on quality by defining the optimal resources for cancer care in areas that were not addressed by previous standards, including defining the critical elements essential for surgical success and the rapid capture and reporting of data that can be used to drive quality improvement efforts.
With an eye toward facilitating the success of CoC-accredited programs, each webinar in the Meeting the 2020 Standards for Optimal Cancer Care series will discuss the value of a specific new standard or standards, describe important new requirements for each standard, and offer recommendations for implementing the changes in accredited programs across the country.
This webinar gives an overview of the six operative standards in the 2020 CoC Standards and identifies how these standards for performing cancer surgery and synoptic operative reports improve care.
- Allied Health Professionals
- Cancer Committee Chairs
- Cancer Liaison Physicians
- Cancer Program Administrators
- Certified Tumor Registrars
- Oncology Nurses
- Understand the rationale that lead to the Standards changes.
- Describe the key changes affecting patient care.
- Formulate strategies to address new requirements.
- Learn about new resources, templates, and online education to support the new standards.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest (see below for definitions).
The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Presenter and Moderator Disclosures
Matthew H.G. Katz, MD, FACS – Nothing to disclose
Department of Surgical Oncology, Division of Surgery
MD Anderson Cancer Center
Kelly K. Hunt, MD FACS – Merck & Co.: Stipend: Medical Advisory Board; Armada Health: Stipend: Medical Advisory Board;
Endomagnetics: Institutional Research Funding: PI; Lumicell, OncoNano: Institutional Research Funding: PI
Professor & Chair
Department of Breast Surgical Oncology, Division of Surgery
MD Anderson Cancer Center
Planning Committee Disclosures
Asa Carter, MBA, CTR – Nothing to disclose
Chantel Ellis – Nothing to disclose
Amanda Francescatti, MS – Nothing to disclose
Linda Zheng – Nothing to disclose
Connie Bura – Nothing to disclose
Vicki Chiappetta – Nothing to disclose
Erin DeKoster – Nothing to disclose
Lauren Dyer – Nothing to disclose
Carolyn Jones – Nothing to disclose
Susanne Kessler – Nothing to disclose
Ryan McCabe – Nothing to disclose
Sue Rubin – Nothing to disclose
Andrea Scrementi – Nothing to disclose
Karen Stachon – Nothing to disclose
Ingrid Katauskas – Nothing to disclose
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Certificate of Completion